Inadequate antimicrobial treatment of infections - A risk factor for hospital mortality among critically ill patients

被引:1327
作者
Kollef, MH
Sherman, G
Ward, S
Fraser, VJ
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Barnes Jewish Christian Hlth Syst, Ctr Qual Management, St Louis, MO USA
关键词
antibiotics; bacteremia; community-acquired infection; critical care; infection; nosocomial infection; outcomes; pneumonia;
D O I
10.1378/chest.115.2.462
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission. Design: Prospective cohort study. Setting: Barnes-Jewish Hospital, a university-affiliated urban teaching hospital. Patients: Two thousand consecutive patients requiring admission to the medical or surgical ICU. Interventions: Prospective patient surveillance and data collection. Measurements and results: One hundred sixty-nine (8.5%) infected patients received inadequate antimicrobial treatment of their infections. This represented 25.8% of the 655 patients assessed to have either community-acquired or nosocomial infections. The occurrence of inadequate antimicrobial treatment of infection was most common among patients with nosocomial infections, which developed after treatment of a community-acquired infection (45.2%), followed by patients with nosocomial infections alone (34.3%) and patients with community-acquired infections alone (17.1%) (p < 0.001). Multiple logistic regression analysis, using only the cohort of infected patients (n = 655), demonstrated that the prior administration of antibiotics (adjusted odds ratio [OR], 3.39; 95% confidence interval [CI], 2.88 to 4.23; p < 0.001), presence of a bloodstream infection (adjusted OR, 1.88; 95% CI, 1.52 to 2.32; p = 0.003), increasing acute physiology and chronic health evaluation (APACHE) II scores (adjusted OR, 1.04; 95% CI, 1.03 to 1.05; p = 0.002), and decreasing patient age (adjusted OR, 1.01; 95% CI, 1.01 to 1.02; p = 0.012) were independently associated with the administration of inadequate antimicrobial treatment. The hospital mortality rate of infected patients receiving inadequate antimicrobial treatment (52.1%) was statistically greater than the hospital mortality rate of the remaining patients in the cohort (n = 1,831) without this risk factor (12.2%) (relative risk [RR], 4.26; 95% CI, 3.52 to 5.15; p < 0.001). Similarly, the infection-related mortality rate for infected patients receiving inadequate antimicrobial treatment (42.0%) was significantly greater than the infection-related mortality rate of infected patients receiving adequate antimicrobial treatment (17.7%) (RR, 2.37; 95% CI, 1.83 to 3.08; p < 0.001). Using a logistic regression model, inadequate antimicrobial treatment of infection was found to be the most important independent determinant of hospital mortality for the entire patient cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; p < 0.001). The other identified independent determinants of hospital mortality included the number of acquired organ system derangements, use of vasopressor agents, the presence of an underlying malignancy, increasing APACHE II scores, increasing age, and having a nonsurgical diagnosis at the time of ICU admission. Conclusions: Inadequate treatment of infections among patients requiring ICU admission appears to be an important determinant of hospital mortality. These data suggest that clinical efforts aimed at reducing the occurrence of inadequate antimicrobial treatment could improve the outcomes of critically ill patients. Additionally, prior antimicrobial therapy should be recognized as an important risk factor for the administration of inadequate antimicrobial treatment among ICU patients with clinically suspected infections.
引用
收藏
页码:462 / 474
页数:13
相关论文
共 48 条
  • [1] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [2] [Anonymous], CHEST
  • [3] Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia
    Baraibar, J
    Correa, H
    Mariscal, D
    Gallego, M
    Valles, J
    Rello, J
    [J]. CHEST, 1997, 112 (04) : 1050 - 1054
  • [4] Community-acquired pneumonia in adults: Guidelines for management
    Bartlett, JG
    Breiman, RF
    Mandell, LA
    File, TM
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838
  • [5] TREATMENT AND PREVENTION OF NOSOCOMIAL PNEUMONIA
    BERGOGNEBEREZIN, E
    [J]. CHEST, 1995, 108 (02) : S26 - S34
  • [6] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [7] INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS
    BRUNBUISSON, C
    DOYON, F
    CARLET, J
    DELLAMONICA, P
    GOUIN, F
    LEPOUTRE, A
    MERCIER, JC
    OFFENSTADT, G
    REGNIER, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12): : 968 - 974
  • [8] Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals
    BrunBuisson, C
    Doyon, F
    Carlet, J
    Bedock, B
    Annonay, CH
    Valente, E
    Lescale, O
    Misset, B
    Charbonneau, P
    Vergnaud, M
    Cohen, R
    Coloignier, M
    Frances, JL
    Combes, A
    Duval, O
    Dellamonica, P
    Descamps, JM
    Domart, Y
    Galiacy, JL
    Gouin, F
    Guivarch, G
    Hennequin, C
    Krajevitch, A
    Delmas, P
    Holzapfel, L
    Lepeu, G
    Loirat, P
    Thaler, F
    Knani, L
    Mercier, JC
    Mouton, Y
    Libbrecht, E
    Offenstadt, G
    Pinaud, M
    Pinsart, M
    Girou, E
    Portier, H
    Grappin, M
    Rebeix, MT
    Regnier, B
    Gachot, B
    Ricome, JL
    Sollet, JP
    Mentec, H
    Tempelhoff, G
    Beuret, P
    Lepoutre, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 617 - 624
  • [9] RAPID DETECTION AND IDENTIFICATION OF CANDIDA-ALBICANS AND TORULOPSIS (CANDIDA) GLABRATA IN CLINICAL SPECIMENS BY SPECIES-SPECIFIC NESTED PCR AMPLIFICATION OF A CYTOCHROME-P-450 LANOSTEROL-ALPHA-DEMETHYLASE (L1A1) GENE FRAGMENT
    BURGENERKAIRUZ, P
    ZUBER, JP
    JAUNIN, P
    BUCHMAN, TG
    BILLE, J
    ROSSIER, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (08) : 1902 - 1907
  • [10] Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711